Haemoglobin recovery among HIV-1 infected patients on zidovudine-based antiretroviral therapy and other regimens in north-central Nigeria

Abstract

We conducted a study to assess trends in haemoglobin recovery among HIV-infected patients initiated on zidovudine-based combination antiretroviral therapy (cART) stratified by baseline haemoglobin level. Haemoglobin data from non-pregnant adult patients initiating cART in rural north-central Nigeria between June 2009 and May 2011 were analysed using a linear mixed effects model to assess the interaction between time, zidovudine-containing regimen and baseline haemoglobin level on the outcome of subsequent haemoglobin level. Best-fit curves were created for baseline haemoglobin in the 10th, 25th, 75th and 90th percentiles. We included 313 patients with 736 measures of haemoglobin in the analysis (239 on zidovudine and 74 on non-zidovudine-containing regimens). Median haemoglobin increased over time in both groups, with differences in haemoglobin response over time related to baseline haemoglobin levels and zidovudine use (p = 0.003). The groups of patients on zidovudine at the 10th and 90th percentiles had downward sloping curves while all other groups had upward trending haemoglobin levels. Although haemoglobin levels increased overall for patients on zidovudine-containing regimens, for those in the 10th and 90th percentiles haemoglobin levels trended downward over time. These results have implications for decisions regarding when to initiate, switch from or avoid the use of zidovudine.

Keywords

HIV AIDS zidovudine AZT anaemia haemoglobin antiretroviral therapy Africa

Get full access to this article

View all access options for this article.

References

World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach, Geneva: WHO Press, 2010.

Richman

Fischl

Grieco

. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987; 317: 192–197.

Matsushita

Yoshimura

Kimura

. Spontaneous recovery of hemoglobin and neutrophil levels in Japanese patients on long-term Combivir containing regimen. J Clin Virol 2005; 33: 188–193.

Sullivan

Hanson

Brooks

. Impact on hemoglobin of starting combination antiretroviral therapy with or without zidovudine in anemic HIV-infected patients. J Acquir Immune Defic Syndr 2008; 48: 163–168.

Kiragga

Castelnuovo

Nakanjako

. Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings. J Int AIDS Soc 2010; 13: 42 doi:10.1186/1758-2652-13-42–42 doi:10.1186/1758-2652-13-42.

Ssali

Stohr

Munderi

. Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. Antivir Ther 2006; 11: 741–749.

Zhou

Jaquet

Bissagnene

. Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific and central and South America. J Int AIDS Soc 2012; 15: 5 doi:10.1186/1758-2652-15-5–5 doi:10.1186/1758-2652-15-5.

Saracino

Nacarapa

da Costa Massinga

. Prevalence and clinical features of HIV and malaria co-infection in hospitalized adults in Beira, Mozambique. Malar J 2012; 11: 241–241.

Modjarrad

Zulu

Redden

. Prevalence and predictors of intestinal helminth infections among human immunodeficiency virus type 1-infected adults in an urban African setting. Am J Trop Med Hyg 2005; 73: 777–782.

10.

Walson

Stewart

Sangare

. Prevalence and correlates of helminth co-infection in Kenyan HIV-1 infected adults. PLoS Negl Trop Dis 2010; 4: e644–e644.

11.

Onyenekwe

Ele

Ukibe

. Assessment of white blood cell count, packed cell volume, phagocytic functions, serum albumin and plasma iron in HIV infected patients. Clin Immunol 2010; 135: S110–S110.

12.

Akinbo

Okaka

Omoregie

. Plasmodium falciparum and intestinal parasitic co-infections in HIV-infected patients in Benin City, Edo State, Nigeria. J Infect Dev Ctries 2012; 6: 430–435.

13.

Igbedioh

. Undernutrition in Nigeria: dimension, causes and remedies for alleviation in a changing socio-economic environment. Nutr Health 1993; 9: 1–14.

14.

Federal Ministry of Health. National guidelines for HIV and AIDS treatment and care in adolescents and adults. Abuja, Nigeria: Ministry of Health – Nigeria, 2010.

15.

Laird

Ware

. Random-effects models for longitudinal data. Biometrics 1982; 38: 963–974.

16.

Hastie

Generalized additive models. In: Chambers

Hastie

(eds). Statistical models in S, Danvers, MA: Chapman and Hall/CRC, 1992.

17.

Moh

Danel

Sorho

. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Cote d'Ivoire. Antivir Ther 2005; 10: 615–624.